Introduction
============

Coronary artery disease (CAD) is a common and disabling disorder. It remains the leading cause of mortality worldwide, resulting in the deaths of 3.8 million men and 3.4 million women annually.[@b1-cia-8-1283] Most individuals with stable CAD show no symptoms and signs for decades, until the sudden onset of coronary events, such as myocardial infarction. Therefore, it is desirable to identify patients at an early stage of CAD, to enable preventive interventions and to promote lifestyle modifications as early as possible.

Traditional risk factors for CAD, such as family history of CAD, age, smoking, hypertension, diabetes mellitus, hyperlipidemia, and obesity have been used to identify asymptomatic individuals who are at higher risk of cardiovascular events.[@b2-cia-8-1283],[@b3-cia-8-1283] However, these risk factors can only identify approximately 50% of patients at risk of CAD.[@b4-cia-8-1283] Carotid ultrasonography has become a prominent focus of clinical research in the last two decades, and the relationship between cardiovascular events, and carotid intima-media thickness (CIMT) and plaque formation, has been studied widely. Many large epidemiological studies have shown a strong relationship between cardiovascular events, and CIMT and plaques.[@b5-cia-8-1283]--[@b8-cia-8-1283] Overall, evidence for the predictive value of carotid plaques for CAD seems consistent,[@b9-cia-8-1283]--[@b13-cia-8-1283] but evidence for the use of CIMT in clinical practice is incomplete, because the predictive value of CIMT for CAD is inconsistent, especially in patients with stable CAD. Some studies have suggested that CIMT could be used as a predictive marker for cardiovascular events,[@b14-cia-8-1283]--[@b16-cia-8-1283] while others have reported that CIMT was not an independent predictor for CAD, after adjustment for traditional risk factors.[@b17-cia-8-1283],[@b18-cia-8-1283] Such conflicting results may be due to considerable variation between studies in relation to measurement methods and cut-off values for CIMT. In addition, most studies have used severe cardiovascular events, such as myocardial infarction, CAD death, or coronary revascularization, as study end-points. However, it is not suitable to apply the results derived from these studies to patients with asymptomatic CAD. A genome-wide study also showed a strong genetic effect on CIMT.[@b19-cia-8-1283] Unfortunately, very few studies are available regarding the age-related predictive value of CIMT and plaques for stable CAD in the Chinese population. Thus, the purpose of this prospective study was to investigate the predictive value of CIMT and plaques for the occurrence of stable CAD.

Material and methods
====================

Patients
--------

Patients who were referred to Cathay General Hospital, Taipei, Taiwan with suspected CAD due to chest pain were consecutively recruited from January 2008--January 2010. Exclusion criteria included a history of myocardial infarction, unstable angina, coronary-artery bypass surgery, stroke, ventricular and supraventricular arrhythmias, contraindications for the use of iodinated contrast medium, history of cervical spine injuries, wounds on the neck, and poor echo imaging. All participants underwent physical examination, noninvasive multislice computed tomography (MSCT) coronary angiography for the diagnosis of CAD, and ultrasonography for the assessment of CIMT and plaques. Hypertension was defined as a blood pressure \>140/90 mmHg, or treatment with any antihypertensive agent. Hyperlipidemia was defined as a total cholesterol level \>5.0 mmol/L, or the use of any antihyperlipidemic agent. Diabetes mellitus was defined as a fasting plasma blood glucose level \>7.0 mmol/L on two different days, a postprandial blood glucose level \>11.1 mmol/L, or the use of antidiabetic medications.

All participants provided informed, written consent. The study was conducted in accordance with the Helsinki II Declaration and approved by the Scientific Ethics Committee of Cathay General Hospital.

MSCT coronary angiography
-------------------------

MSCT coronary angiography was performed with a 64-slice MSCT scanner (Aquilion 64, Toshiba Medical Systems, Otawara-shi, Japan). A nonenhanced prospective electrocardiographically-gated scan was performed first, to determine the start and end position of the following helical scan, through which coronary angiography was performed. The presence of coronary atherosclerosis was visually evaluated based on axial images and curved multiplanar reconstructions in two orthogonal planes. Obstructive coronary atherosclerosis was defined as a luminal narrowing \>50% in one or more coronary arteries.

Carotid ultrasonography
-----------------------

Carotid ultrasonography was performed within 24 hours following MSCT coronary angiography. The carotid arteries were evaluated using a high resolution B-mode color Doppler and pulse Doppler ultrasound system (iE33 xMATRIX, Philips Healthcare, Andover, MA, USA) with a transducer frequency of 11--13 MHz, by an examiner who was blind to the subjects' characteristics. The near and far wall of the right and left common carotid arteries (CCAs) (at least 1.5 cm proximal to the origin of the carotid bulb \[CB\], bifurcations at the CB), and proximal internal carotid arteries (ICAs) were scanned. Using an automated edge detection algorithm, the maximum IMT was determined as the distance between the lumen--intima interface and the media--adventitia interface at a plaque-free segment in end-diastole. The maximum IMT of the CCA, ICA, and CB was recorded. Mean CIMT was defined as the average of IMT values at the right and left sides of the CCA, ICA, and CB. A carotid plaque in the CCA, CB, or ICA was defined either as (1) a thickening of the focal wall that was at least 50% greater than the thickening of the surrounding vessel wall (relative plaque), or (2) a focal region with an IMT of \>1.5 mm (absolute plaque).[@b20-cia-8-1283]

Statistical analysis
--------------------

Statistical analysis was conducted using SPSS software version 19.0 (IBM Corporation, Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation, and categorical variables were expressed as number (%). The Student's *t*-test or Mann--Whitney *U* test was performed for between-group comparisons of continuous variables (according to distribution characteristics), while the chi-square test was used to perform between-group comparisons of categorical variables. Partial correlation analysis was performed to test the correlation between CAD and CIMT or plaques, controlling for age, diabetes mellitus, hyperlipidemia, hypertension, smoking, and family history of CAD. Multivariate logistic regression analysis (with CAD as the outcome variable) was performed to determine the independent predictors of CAD. Two-tailed tests were performed, and a value of *P* \< 0.05 was considered statistically significant.

Results
=======

Patient characteristics
-----------------------

A total of 120 patients were recruited into the study, including 95 males and 25 females, with a mean age of 61 ± 11 years (range: 35--89 years). Age had a significant impact on CAD (*r* = 0.191; *P* = 0.036), CCA plaques (*r* = 0.368; *P* = 0.001), ICA plaques (*r* = 0.334; *P* = 0.004), and CIMT (*r* = 0.436; *P* = 0.001). As most Chinese retire at the age of 60 years, and their lifestyles may change dramatically after retirement, we separated patients into two groups (\<60 years and ≥60 years) for further analysis. As shown in [Table 1](#t1-cia-8-1283){ref-type="table"}, compared with patients \<60 years old, patients ≥60 years old had a higher incidence of hypertension (*P* = 0.018), and more severe CAD (involving three coronary arteries; *P* = 0.015). No difference was found between the two groups in terms of sex or CAD risk factors, such as family history of CAD, smoking, diabetes mellitus, and hyperlipidemia (*P* \> 0.05, for each).

CIMT and its correlation with CAD
---------------------------------

In the \<60 year group, only IMT-CB was significantly higher in patients with CAD, as compared to those without CAD (*P* = 0.041), while in the ≥60 years group, mean CIMT, IMT-CCA, and IMT-CB were significantly higher in patients with CAD than in those without CAD (*P* \< 0.05, for each). Comparing the two age groups, mean CIMT and IMT-CCA were significantly higher in the ≥60 years group than those in the \<60 years group (*P* \< 0.0001, for each) ([Table 2](#t2-cia-8-1283){ref-type="table"}). After controlling for other CAD risk factors (age, family history of CAD, smoking, diabetes mellitus, hypertension, and hyperlipidemia), partial correlation analysis showed that only IMT-CB was correlated with CAD in the \<60 years group (*P* = 0.041), but that mean CIMT, IMT-CCA, and IMT-CB were all correlated with CAD in the ≥60 years group (*P* \< 0.05, for each) ([Table 3](#t3-cia-8-1283){ref-type="table"}). These results suggest that IMT-CB was more specific for predicting the relationship between CIMT and CAD in both age groups, while mean CIMT and IMT-CCA were only valuable in patients ≥60 years old.

Carotid plaques and correlation with CAD
----------------------------------------

Of the 120 patients, 27 (22.5%) had no carotid plaques, and 93 (77.5%) had plaques, of whom 16 (13.3%) had plaques at one site, 40 (33.3%) had plaques at two sites, and 37 (30.8%) had plaques at three sites. As shown in [Table 4](#t4-cia-8-1283){ref-type="table"}, the proportion of patients with plaques at all sites (CCA, ICA, and CB) was significantly higher in patients with CAD than in those without CAD, in both age groups (*P* \< 0.007, for each). However, the proportion was higher in patients aged ≥60 years, compared against those aged \<60 years (*P* \< 0.05, for each). After controlling for other CAD risk factors (age, family history of CAD, smoking, diabetes mellitus, hypertension, and hyperlipidemia), partial correlation analysis showed that carotid plaques in the CCA and CB were significantly correlated with CAD in patients aged \<60 years (*P* \< 0.05, for each), whereas plaques in all sites were correlated with CAD in those aged ≥60 years (*P* \< 0.05, for each) ([Table 3](#t3-cia-8-1283){ref-type="table"}).

CAD risk prediction
-------------------

By controlling for other CAD risk factors, multivariate logistic regression analysis (with CAD as the outcome variable) showed that only IMT-CB was an independent predictor of CAD in patients ≥60 years old (*P* = 0.031), but not in patients \<60 years old. However, carotid plaques were an independent predictor of CAD in patients \<60 and ≥60 years old (*P* = 0.006 and *P* = 0.045, respectively) ([Table 5](#t5-cia-8-1283){ref-type="table"}).

Discussion
==========

The present study analyzed the relationship between carotid atherosclerosis and stable angiographic CAD. We found that CIMT was not an independent predictor of CAD in patients \<60 years old, but that IMT-CB could predict CAD in patients ≥60 years old, after adjustment for traditional risk factors. Carotid plaques in the CCA or CB were strongly correlated with CAD in all patients, and multivariate logistic regression analysis showed that this was an independent predictor of CAD in all patients.

Our findings regarding the predictive value of CIMT differ from those of previous studies. Kablak-Ziembicka et al[@b18-cia-8-1283] examined IMT at the CCA, ICA, and CB in 558 consecutive patients referred for coronary angiography. They reported that CIMT was strongly correlated with the presence and severity of CAD, particularly in women. However, there were some significant limitations to that study. First, the CIMT maximum included plaque, which would significantly increase the predictive value of CIMT. Second, the mean CIMT values among patients with no disease and 1-, 2- and 3-vessel disease overlapped substantially. Moreover, many patients had a history of myocardial infarction, which places them in a high-risk group. In another study, Timoteo et al[@b21-cia-8-1283] measured maximum IMT and plaques at the CCA in 300 patients with suspected stable CAD, and found that the maximum IMT at the CCA was an independent predictor of CAD, together with age, sex, and diabetes mellitus. The Atherosclerosis Risk in Communities (ARIC) study,[@b22-cia-8-1283] which recruited subjects between 45--64 years old, also found that CIMT and plaque information can be used to improve CAD risk prediction, and was equal or superior to other contemporary markers.

Debate remains active as to which carotid segment should be used to measure IMT. The ARIC study examined whether IMT-CCA was as good as all-segment IMT for the prediction of vascular events, when added to traditional risk factor and plaque information. No difference between the two measures was found, suggesting that IMT-CCA was sufficient for use in clinical risk assessment.[@b22-cia-8-1283] However, in the Three-City Study,[@b23-cia-8-1283] IMT was examined at the CCA in 5,895 CAD-free adults aged 65--85, and the results indicated that CIMT at a plaque-free site failed to predict CAD events, such as hospitalization for angina pectoris, myocardial infarction, CAD death, or a revascularization procedure (percutaneous intervention or coronary artery bypass or grafting). Although the measurement of IMT at the CCA is more reproducible than that measured at the ICA or bifurcation,[@b24-cia-8-1283] disease progression is more obvious in the ICA and bifurcation.[@b5-cia-8-1283] Therefore, measuring only IMT-CCA may underestimate carotid atherosclerosis. In the present study, we measured IMT at the CCA, ICA, and CB, and found that CIMT measured at all sites could not predict CAD in patients \<60 years old, while in patients ≥60 years old, IMT-CB could weakly predict CAD. These results suggest that CIMT should be assessed in all carotid segments in order to avoid underestimation of carotid atherosclerosis.

In the present study, CIMT was assessed in the carotid segments free of plaques because, although correlated, increased CIMT and the presence of plaques represent different stages and aspects of atherosclerosis. Diffuse adaptive thickening of the carotid wall reflects arteriosclerosis, responding to aging and hypertension, while plaque formation is a focal process, and is more related to atherosclerotic processes, such as inflammation, oxidation, and endothelial dysfunction,[@b25-cia-8-1283],[@b26-cia-8-1283] which may be more strongly associated with the pathology of CAD. A recent meta-analysis of eleven population-based studies by Inaba et al[@b27-cia-8-1283] showed that carotid plaques, compared against CIMT, had a significantly higher diagnostic accuracy for prediction of future coronary events. In the present study, we found also that correlation between carotid plaques and the severity of CAD was consistent in patients below and above 60 years old.

We separated patients into two groups at 60 years of age because we had found, along with others,[@b6-cia-8-1283] that age has a significant impact on CIMT and plaque formation. In addition, in the People's Republic of China, most people have dramatic lifestyle changes following retirement at the age of 60, which can affect their health condition. We found that the predictive value of CIMT for CAD was different in patients under and over 60 years of age, suggesting that age plays an extremely important role in CAD and plaque formation. This may help to explain why the predictive value of CIMT for CAD is inconsistent in previous studies, as they included different age groups of patients. We believe the present findings, based on the comparison between these two age groups, will be more useful for clinical decision making. The American Heart Association's Prevention Conference V recommended CIMT scanning for patients who are older than 45, and requiring further clarification of their CAD risks.[@b28-cia-8-1283] Although carotid ultrasonography is easy and quick to perform, it requires expensive equipment and specific operator training. To perform carotid scanning for a target population older than 45 years would have an enormous cost. We think it may be more efficient and useful to target those aged over 60 years, with CAD risk factor assessment.

There are certain limitations to the present study. Firstly, the study sample is relatively small for multivariate logistic regression analysis, which may affect the significance of the results. For example, the ARIC Study[@b22-cia-8-1283] recruited a population-based cohort of 15,792 subjects; the 25th and 75th percentile CIMT values were only 0.65 mm and 0.84 mm, for men, and 0.58 mm and 0.74 mm, for women, respectively, which are much lower than our measurements. However, our results still suggest that CIMT and plaque information can be used to improve CAD risk prediction, and may be equivalent or superior to other contemporary markers. Secondly, in our study, the proportion of women was small. It has been reported that patients with chest pain and normal coronary angiographies are predominantly women.[@b29-cia-8-1283] However, age- and sex-related differences in the prevalence of CAD are well recognized: male patients tend to have earlier onset of CAD;[@b30-cia-8-1283] therefore, male patients predominate. Finally, the incidence of plaques was relatively high in our study. This may reflect a true patient population in the People's Republic of China, because only patients who are considered to be at high risk of CAD will be referred for CT angiography.

Conclusion
==========

Our findings suggest that carotid plaque formation is a strong predictor of stable CAD. However, CIMT-CB could predict stable CAD only in patients aged over 60. Further study with a larger sample size is warranted.
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###### 

Patient characteristics

                                         Total       \<60 years (n = 61)   ≥60 years (n = 59)   *P*
  -------------------------------------- ----------- --------------------- -------------------- -------
  Age (years)                            61 ± 11     52 ± 5                71 ± 7               0.000
  Males                                  95 (79.2)   51 (83.6)             44 (74.6)            NS
  CAD risk factors                                                                              
   Family CAD history                    21 (17.5)   10 (16.4)             11 (18.6)            NS
   Smoking                               65 (54.2)   35 (57.4)             30 (50.8)            NS
   Diabetes                              46 (38.3)   20 (33.3)             26 (44.1)            NS
   Hypertension                          88 (73.3)   39 (63.9)             49 (83.1)            0.018
   Hyperlipidemia                        57 (47.5)   32 (52.5)             25 (42.4)            NS
  Number of diseased coronary arteries                                                          
   0                                     32 (26.7)   19 (31.1)             13 (22.0)            NS
   1                                     19 (15.8)   12 (19.7)             7 (11.9)             NS
   2                                     20 (16.7)   12 (19.7)             8 (13.6)             NS
   3                                     49 (40.8)   18 (29.5)             31 (52.5)            0.015

**Note:** Data are presented as mean ± standard deviation, or number (percentage).

**Abbreviations:** CAD, coronary artery disease; NS, not significant.

###### 

Difference in carotid intima-media thickness between the two age groups of patients, with and without coronary artery disease

                   \<60 years (n = 61)   ≥60 years (n = 59)   *P*
  ---------------- --------------------- -------------------- -------
  Mean CIMT (mm)                                              
   Non-CAD         0.65 ± 0.02           0.72 ± 0.04          NS
   CAD             0.68 ± 0.02           0.81 ± 0.02          0.000
   *P*             NS                    0.028                
  IMT-CCA (mm)                                                
   Non-CAD         0.84 ± 0.02           0.88 ± 0.04          NS
   CAD             0.85 ± 0.02           0.97 ± 0.02          0.000
   *P*             NS                    0.036                
  IMT-CB (mm)                                                 
   Non-CAD         0.87 ± 0.02           0.85 ± 0.03          NS
   CAD             0.93 ± 0.02           0.98 ± 0.02          NS
   *P*             0.041                 0.001                

**Note:** Data are presented as mean ± standard deviation.

**Abbreviations:** CIMT, carotid intima-media thickness; CCA, common carotid artery; CB, carotid bulb; CAD, coronary artery disease; NS, not significant.

###### 

The correlation between carotid IMT and plaque with the incidence of CAD, after controlling for other risk factors

               \<60 years   ≥60 years           
  ------------ ------------ ----------- ------- -------
  Mean CIMT    0.125        0.336       0.286   0.028
  IMT-CCA      0.028        0.829       0.274   0.036
  IMT-CB       0.263        0.041       0.424   0.001
  CCA plaque   0.319        0.012       0.347   0.007
  ICA plaque   0.168        0.195       0.288   0.027
  CB plaque    0.255        0.047       0.481   0.000

**Abbreviations:***r*, correlation coefficient; IMT, intima-media thickness; CIMT, common carotid intima-media thickness; CAD, coronary artery disease; CCA, common carotid artery; CB, carotid bulb; ICA, internal carotid artery.

###### 

Difference of carotid plaque occurrence between the two age groups of patients, with and without coronary artery disease

               \<60 years (n = 61)   ≥60 years (n = 59)   *P*
  ------------ --------------------- -------------------- -------
  CCA plaque                                              
   Non-CAD     2 (3.3)               6 (10.2)             0.028
   CAD         18 (28.7)             38 (64.4)            0.000
   *P*         0.000                 0.000                
  ICA plaque                                              
   Non-CAD     4 (6.6)               5 (8.5)              NS
   CAD         16 (25.4)             33 (55.9)            0.002
   *P*         0.007                 0.000                
  CB plaque                                               
   Non-CAD     8 (13.2)              6 (10.2)             NS
   CAD         29 (47.5)             42 (71.2)            0.014
   *P*         0.000                 0.000                

**Note:** Data are presented as number (percentage).

**Abbreviations:** CAD, coronary artery disease; CCA, common carotid artery; ICA, internal carotid artery; CB, carotid bulb; NS, not significant.

###### 

Prediction of coronary artery disease by carotid IMT and plaque

                   \<60 years           ≥60 years                          
  ---------------- -------------------- ----------- ---------------------- -------
  Mean CIMT        1.42 (0.46--4.34)    0.540       1.79 (0.45--7.06)      0.408
  IMT-CCA          2.23 (0.70--7.09)    0.174       0.92 (0.24--3.61)      0.905
  IMT-CB           0.73 (0.25--2.13)    0.560       3.86 (1.13--13.23)     0.031
  Carotid plaque   5.36 (1.63--17.63)   0.006       14.91 (1.06--209.84)   0.045

**Abbreviations:** OR, odds ratio; CI, confidence interval; CIMT, carotid intima-media thickness; CCA, common carotid artery; CB, carotid bulb.
